Choi Charles, Johnson Danica E, Chen-Li David, Rosenblat Joshua
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Mood Disorders Psychopharmacology Unit, Poul Hansen Depression Center, University Health Network, Toronto, ON, Canada.
J Psychopharmacol. 2024 Oct 3:2698811241286771. doi: 10.1177/02698811241286771.
Posttraumatic stress disorder (PTSD) is a condition that can develop after a traumatic event, causing distressing symptoms, including intrusive re-experiencing symptoms, alterations in mood and cognition, and changes in arousal and reactivity. Few treatment options exist for patients who find conventional psychotherapy and pharmacotherapy to be inaccessible, ineffective, or intolerable. We explore psilocybin as a potential treatment option for PTSD by examining the neurobiology of PTSD as well as psilocybin's mechanism of action. Based on both pharmacodynamic and psychoanalytic principles, psilocybin may be an underexplored treatment option for patients with PTSD, though further research is required.
创伤后应激障碍(PTSD)是一种在创伤事件后可能出现的病症,会引发令人痛苦的症状,包括反复出现的侵入性症状、情绪和认知的改变,以及觉醒和反应性的变化。对于那些认为传统心理治疗和药物治疗无法获得、无效或无法耐受的患者,几乎没有其他治疗选择。我们通过研究PTSD的神经生物学以及裸盖菇素的作用机制,探讨裸盖菇素作为PTSD潜在治疗选择的可能性。基于药效学和精神分析学原理,裸盖菇素可能是PTSD患者一种未被充分探索的治疗选择,不过仍需要进一步研究。